A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030.

IF 3.4 3区 医学 Q2 ONCOLOGY
Journal of Hepatocellular Carcinoma Pub Date : 2025-07-16 eCollection Date: 2025-01-01 DOI:10.2147/JHC.S528033
Kelsey S Lau-Min, Thomas Abrams, Andrea Bullock, Alyson Kaplan, Leslie Salas Karnes, Mark W Kennedy, Christina A LeBedis, Ming V Lin, Nadine Jackson McCleary, Shirin Sioshansi, Emma Voligny, Elizabeth Paige Walsh, Christopher R Manz
{"title":"A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030.","authors":"Kelsey S Lau-Min, Thomas Abrams, Andrea Bullock, Alyson Kaplan, Leslie Salas Karnes, Mark W Kennedy, Christina A LeBedis, Ming V Lin, Nadine Jackson McCleary, Shirin Sioshansi, Emma Voligny, Elizabeth Paige Walsh, Christopher R Manz","doi":"10.2147/JHC.S528033","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality in the United States. Disparities in HCC incidence and mortality are amplified in Boston, Massachusetts, which has 42% higher HCC mortality than the nation. HCC-CARE was a one-day symposium that aimed to identify goals and strategies necessary to eliminate HCC disparities in the Greater Boston area by 2030. Sixty-six local and state stakeholders attended the symposium, including HCC clinical experts (eg, medical oncologists) and primary care clinicians representing all seven of Boston's major cancer centers, ancillary staff members (eg, social workers) and state and local government agencies. The symposium included introductory sessions on HCC disparities, conceptual approaches to addressing disparities, and perspectives of local stakeholders on HCC disparities, followed by two interactive workshops where nine groups brainstormed and voted on goals, then developed preliminary action plans. Symposium participants identified four priority goals and developed associated action plans to eliminate HCC disparities by 2030: 1) improving HCC screening rates to enable early detection, 2) employing community engagement and outreach to communities at high risk of HCC, 3) developing a multi-institutional HCC registry to inform care delivery improvements, and 4) connecting patients with HCC to support services to address common barriers to care. A fifth priority around addressing disparities in HCC treatment emerged from post-symposium feedback. HCC-CARE established a knowledge base and raised the saliency of HCC disparities among participants, created a multi-institutional consortium of individuals committed to addressing HCC disparities, and leveraged the wide-ranging expertise of the participants to identify key goals and strategies for achieving equity in HCC outcomes by 2030. These strategies require further development and implementation through multi-institutional committees established after the symposium for each priority area. The Symposium represented a key first step in launching coordinated efforts to reduce HCC disparities that other cities may emulate.</p>","PeriodicalId":15906,"journal":{"name":"Journal of Hepatocellular Carcinoma","volume":"12 ","pages":"1417-1424"},"PeriodicalIF":3.4000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301847/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatocellular Carcinoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JHC.S528033","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality in the United States. Disparities in HCC incidence and mortality are amplified in Boston, Massachusetts, which has 42% higher HCC mortality than the nation. HCC-CARE was a one-day symposium that aimed to identify goals and strategies necessary to eliminate HCC disparities in the Greater Boston area by 2030. Sixty-six local and state stakeholders attended the symposium, including HCC clinical experts (eg, medical oncologists) and primary care clinicians representing all seven of Boston's major cancer centers, ancillary staff members (eg, social workers) and state and local government agencies. The symposium included introductory sessions on HCC disparities, conceptual approaches to addressing disparities, and perspectives of local stakeholders on HCC disparities, followed by two interactive workshops where nine groups brainstormed and voted on goals, then developed preliminary action plans. Symposium participants identified four priority goals and developed associated action plans to eliminate HCC disparities by 2030: 1) improving HCC screening rates to enable early detection, 2) employing community engagement and outreach to communities at high risk of HCC, 3) developing a multi-institutional HCC registry to inform care delivery improvements, and 4) connecting patients with HCC to support services to address common barriers to care. A fifth priority around addressing disparities in HCC treatment emerged from post-symposium feedback. HCC-CARE established a knowledge base and raised the saliency of HCC disparities among participants, created a multi-institutional consortium of individuals committed to addressing HCC disparities, and leveraged the wide-ranging expertise of the participants to identify key goals and strategies for achieving equity in HCC outcomes by 2030. These strategies require further development and implementation through multi-institutional committees established after the symposium for each priority area. The Symposium represented a key first step in launching coordinated efforts to reduce HCC disparities that other cities may emulate.

Abstract Image

HCC-CARE研讨会总结:到2030年在波士顿实现肝细胞癌公平的合作方法
肝细胞癌(HCC)是美国癌症死亡的主要原因。在马萨诸塞州波士顿,HCC发病率和死亡率的差异进一步扩大,其HCC死亡率比全国高42%。HCC- care是一个为期一天的研讨会,旨在确定到2030年消除大波士顿地区HCC差异所需的目标和策略。66个地方和州的利益相关者参加了研讨会,包括HCC临床专家(如肿瘤医学专家)和代表波士顿所有7个主要癌症中心的初级保健临床医生、辅助工作人员(如社会工作者)以及州和地方政府机构。研讨会包括介绍HCC差异、解决差异的概念方法以及当地利益相关者对HCC差异的看法,随后是两个互动研讨会,九个小组进行了头脑风暴并就目标进行了投票,然后制定了初步行动计划。与会者确定了到2030年消除HCC差异的四个优先目标,并制定了相关的行动计划:1)提高HCC筛查率以实现早期发现;2)采用社区参与和向HCC高风险社区推广;3)建立多机构HCC登记,以告知改善护理服务;4)将HCC患者与支持服务联系起来,以解决常见的护理障碍。关于解决HCC治疗差异的第五个优先事项来自研讨会后的反馈。HCC- care建立了一个知识库,提高了参与者之间HCC差异的显著性,创建了一个由致力于解决HCC差异的个人组成的多机构联盟,并利用参与者广泛的专业知识来确定到2030年实现HCC结果公平的关键目标和策略。这些战略需要通过专题讨论会之后为每个优先领域设立的多机构委员会进一步发展和执行。研讨会代表了启动协调努力以减少HCC差异的关键的第一步,其他城市可以效仿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.50
自引率
2.40%
发文量
108
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信